Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

AHMEDABAD: Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila’s manufacturing facility near Ahmedabad. Wearing a PPE kit, Modi reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area, over 20 km from Ahmedabad.

After his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the promoters and executives of the company, an official said.

Modi spent over an hour at the plant, before leaving for the airport, from where will fly to Hyderabad.

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August.

In Hyderabad, Modi is scheduled to visit vaccine maker Bharat Biotech’s facility.

After landing at Hakimpet Air Force station, Modi will reach Bharat Biotech’s facility at Genome Valley at 1.30 pm. The facility is around 50 km from Hyderabad.

Bharat Biotech’s Covaxin is undergoing phase-3 trials.

After his hour-long visit to the facility, the PM will proceed to Pune, where he will visit the Serum Institute of India (SII), which has partnered with global pharma giant AstraZeneca and the Oxford University for the vaccine.

The prime minister will reach Serum Institute campus around 4.30 pm, an official said.

Modi’s hour-long visit to SII is aimed at reviewing the status of the vaccine candidate for coronavirus infection and to know about its launch, production and distribution mechanism, he said.

The PM will fly back to Delhi in the evening, the official said.

  • Related Posts

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    The nurses have been booked under BNS Sections 106 and 286 at the Bagsewania police station. While Ms. Sharma allegedly administered the wrong injection, Ms. Gujarati had left the toxic…

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    Telangana: In a major enforcement action targeting the pharmaceutical supply chain, the Drugs Control Administration (DCA) in Telangana has busted a sophisticated racket involving the illegal label-tampering and misrepresentation of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    Price cap on 2 key cancer drugs increased by 50%

    Price cap on 2 key cancer drugs increased by 50%

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection